Table 4.
Comparison of clinical and laboratory indicators in patients based on the anakinra treatment and intensive care hospitalization
| PICU Admission | Anakinra therapy | |||||
|---|---|---|---|---|---|---|
| Present (n = 21) | Absent (n = 46) | p | Present (n = 17) | Absent (n = 50) | p | |
| Age (months)* | 132.48 | 98.6 | 0.04 | 134 | 95 | 0.07 |
| NLR | 13.0 | 5.31 | 0.00 | 9.4 | 4.2 | 0.00 |
| Hyponatremia (n/%) | 16/76.1 | 15/32.6 | 0.01 | 14/82.3 | 17/34 | 0.00 |
| Bradicardia (n/%) | 8/38 | 0/0 | 0.00 | 7/41.1 | 1/2 | 0.00 |
| Myocarditis (n/%) | 13/61.9 | 10/21.7 | 0.02 | 8/47 | 15/30 | 0.16 |
| Rash (n/%) | 12/57.1 | 14/66.6 | 0.03 | 11/64.7 | 15/30 | 0.01 |
| Hypoalbuminemia (n/%) | 20/95.2 | 11/52.3 | 0.00 | 16/94.1 | 11/22 | 0.00 |
*median, PICU: Pediatric intensive care unit, NLR: Neutrophil/Lymphocyte ratio